FMCSA Clearinghouse

/in /by

 

 

 

 

The U.S. Department of Transportation’s Federal Motor Carrier Safety Administration’s Clearinghouse will become operational on January 6, 2020, and FMCSA-regulated employers must be ready to comply with the Clearinghouse requirements on that date. The FMCSA Clearinghouse is an electronic database that will contain information about commercial motor vehicle drivers’ drug and alcohol program violations. Although the Clearinghouse rule actually took effect on January 4, 2017, the implementation date for FMCSA-regulated employers is January 6, 2020. See 49 CFR Part 382, Subpart G, among others.

https://www.drugtestlawadvisor.com/2016/12/fmcsa-finalizes-rule-on-national-drug-and-alcohol-testing-clearinghouse/The Clearinghouse rule requires FMCSA-regulated employers, Medical Review Officers, Substance Abuse Professionals, consortia/third-party administrators and other service agents to report to the Clearinghouse information related to violations of FMCSA’s drug and alcohol testing regulations by current and prospective employees. In addition:

  • Employers must query the Clearinghouse for current and prospective employees’ drug and alcohol program violations before permitting those employees to operate a commercial motor vehicle on public roads.
  • Employers are required to query the Clearinghouse annually for each driver they currently employ.
  • State driver licensing agencies will be required to query the Clearinghouse whenever a CDL (commercial driver’s license) is issued, renewed, transferred or upgraded.

Here are the important dates that FMCSA-regulated employers must be aware of, and steps to take to prepare for compliance:

Fall 2019:

Register with the Clearinghouse. Employers (and their service agents) should log on to the FMCSA Clearinghouse to register with the Clearinghouse and become familiar with the site. See: https://clearinghouse.fmcsa.dot.gov/. Clearinghouse registration is valid for five years, unless cancelled or revoked.

Revise Drug and Alcohol Testing PolicIn addition, FMCSA regulations require employers to add language to their FMCSA drug and alcohol testing policies to notify drivers and driver-applicants that the following information will be reported to the Clearinghouse:

  • A verified positive, adulterated, or substituted drug test result;
  • An alcohol confirmation test with a concentration of 0.04 or higher;
  • A refusal to submit to a drug or alcohol test;
  • An employer’s report of actual knowledge, as defined at 49 CFR § 382.107;
  • On duty alcohol use pursuant to 49 CFR § 382.205;
  • Pre-duty alcohol use pursuant to 49 CFR § 382.207;
  • Alcohol use following an accident pursuant to 49 CFR § 382.209;
  • Drug use pursuant to 49 CFR § 382.213;
  • A SAP’s report of the successful completion of the return-to-duty process;
  • A negative return-to-duty test; and,
  • An employer’s report of completion of follow-up testing.

January 6, 2020:

Queries of New Hires/Transfers: Employers must query the Clearinghouse before allowing a newly-hired commercial motor vehicle driver (or current employee who transfers into such a position) to begin operating a commercial motor vehicle. Drivers must sign a consent form allowing the employer to do so.

Annual Queries of Current Employees. Employers must query the Clearinghouse at least once per year for each driver they currently employ. Drivers must sign a consent form allowing the employer to do so. The employer must maintain records of all queries and information obtained in response to the query, for a period of three years. (As of January 6, 2023, an employer who maintains a valid registration fulfills this requirement).

Reporting of Drug and Alcohol Program Violations. Employers must report drivers’ drug and alcohol program violations (listed in the bullet points above) to the Clearinghouse within three business days after the employer learns of the information.

Employers must prohibit drivers who have violated FMCSA’s drug and alcohol program regulations from performing safety-sensitive duties unless the driver complies with the return-to-duty process set forth at 49 CFR Part 40, Subpart O (requiring SAP evaluation, possible treatment, return-to-duty testing and follow-up testing).

January 6, 2023:

Safety Performance History Investigations. In addition to the items listed above, employers also will be required to conduct the drug and alcohol testing portion of the safety performance history investigation of driver-applicants through the Clearinghouse. Employers still will be required to obtain the other information required by the safety performance history investigation regulations (e.g., accident history) directly from the driver-applicants’ previous DOT-regulated employers, because that information is not reported to the Clearinghouse.

Employers who do not comply with the FMCSA Clearinghouse requirements are subject to the civil and/or criminal penalties set forth at 49 U.S.C. 521(b)(2)(C) (i.e., civil penalties not to exceed $2,500 for each offense).

FMCSA-regulated employers should review and revise their drug and alcohol testing policies and become familiar with the Clearinghouse requirements before the implementation date.

Glutathione (GSH)

/in /by

Glutathione (GSH) Nitribooster

Glutathione is the body’s own master antioxidant, and essential in many biological processes in human body. Based on clinical researches posted www.PubMed.gov GSH was proven to improve your immune system, maximize the function of antioxidant, and support detoxification, and increase energy, strength level.

The GSH is a protein composed of 3 amino acids: Cysteine, Glutamine, Glycine, has produced by liver, and naturally present in the body from birth to death. But as we age the level GSH reduced at an average rate of 10% per decade after age 20, and we need supplements. The sources of GSH are garlic, onions, broccoli, Brussels spoors, parsley, spinach, beets, avocado, squash, asparagus, grapefruit, apples, oranges, peaches, bananas, melon, cherries, dairy products and eggs.

According researched to date, raising GSH level has been Clinically Proven to be beneficial for people diagnosed:

  • AIDS
  • Alzheimer’s
  • Asthma
  • All Cancers
  • Diabetes
  • Chronic Fatig
  • Autoimmune disorder
  • Glaucoma
  • Kidney, Liver, Lungs
  • Hepatitis
  • Multiply Sclerosis
  • Heart diseases

Glutathione (GSH) Deficiency:

The GSH deficiency occurs when your body is unable to produce enough glutathione, and become the main cause onset of the disease, or its progression, severity. According the research published in “Clinical Epidemiology”, “ The Immune System Care” journals has shown that most of chronic conditions reveals GSH’s deficiency.

Also, reducing the glutathione level may present in people to be in a good health stage. There are several reasons for that one of them is age, because GSH production reduced naturally an average rate of 10% per decade after age 20. Next is exposed to smoke, environmental pollution, viruses, and consumes not proper nutrition on daily basis.

The symptoms may include:

  • Dry skin
  • Headache
  • Dizziness
  • Sleep Disorder
  • Weakness/Lack of energy
  • Depression
  • Brain “fog”
  • Joint pain
  • Rashes
  • Onset of a more serious health condition

What does GSH do in our bodies?

Detoxification – the glutathione destroys large numbers of toxins and radiations by convert in soluble compound then being excreted through the urine or bile.
Antioxidant – GSH is the powerful antioxidant to remove of toxins from body. The proper function of GSH makes positively effect on biomechanical processes in the bodies.
Repair DNA – Free radicals is constantly attack our body, and nearest molecules to “stealing” its electron. A molecule that loses electron then converts in a free radical. Once its started over and over, and converted cell dies or mutated. At times, the mutated cell converted to cancer. To replacing the missing electron in mutated cell performs by GSN, and elevated and maintaining GSH level can help to minimize mutation of DNA cells.

Increase energy – the biomechanical mechanism within your cells effect on our energy level, to muscle function, and even your sense of well-being. Clinical researches have shown that GSH includes mitochondria of a cell, enchanting muscle strength and endurance.
Side effect and contraindications: GSH is mostly safe for adults when taken by intramuscular, intravenous injections. The possible side effects are not known.
Special Precautions & Warning: if you are pregnant and/or breast – feeding you have to get doctor’s consultation. The medicine doesn’t have enough researches about GSH in pregnancy.